We are live on
!
Find out more
ProShare Advisors Portfolio holdings
AUM
$67.5B
1-Year Est. Return
28.09%
This Quarter
Est. Return
-4.19%
1 Year Est. Return
+28.09%
3 Year Est. Return
+88.43%
5 Year Est. Return
+118.21%
10 Year Est. Return
+464.8%
AUM
$26.1B
AUM Growth
-$4.09B
(-14%)
Cap. Flow
-$2.77B
Cap. Flow
% of AUM
-10.63%
Top 10 Holdings %
Top 10 Hldgs %
22.95%
Holding
1,846
New
56
Increased
388
Reduced
1,301
Closed
96
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Target
TGT
|
+$49.4M |
| 2 |
Nucor
NUE
|
+$35.6M |
| 3 |
Essex Property Trust
ESS
|
+$27.5M |
| 4 |
Archer Daniels Midland
ADM
|
+$27.3M |
| 5 |
McCormick & Company Non-Voting
MKC
|
+$21.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$366M |
| 2 |
Microsoft
MSFT
|
+$279M |
| 3 |
Amazon
AMZN
|
+$213M |
| 4 |
Tesla
TSLA
|
+$109M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$104M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.74% |
| 2 | Consumer Staples | 11.79% |
| 3 | Consumer Discretionary | 11.57% |
| 4 | Industrials | 10.74% |
| 5 | Healthcare | 10.7% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
651
Nordson
NDSN
$16.5B
| $1.6M | 0.01% |
7,519
-821
| -10% | -$184K |
|
652
Ralph Lauren
RL
$22.2B
| $1.58M | 0.01% |
18,586
-905
| -5% | -$85.3K |
|
653
Seagate
STX
$193B
| $1.58M | 0.01% |
29,581
-4,546
| -13% | -$329K |
|
|
WRK
654
DELISTED
WestRock Company
WRK
| $1.58M | 0.01% |
51,027
+4,804
| +10% | +$190K |
|
655
BioMarin Pharmaceuticals
BMRN
$11.5B
| $1.57M | 0.01% |
18,556
+1,119
| +6% | +$99.6K |
|
656
Generac Holdings
GNRC
$11.9B
| $1.57M | 0.01% |
8,820
-1,033
| -10% | -$237K |
|
657
Neurocrine Biosciences
NBIX
$17.7B
| $1.57M | 0.01% |
14,796
+534
| +4% | +$54.2K |
|
658
Rexford Industrial Realty
REXR
$8.7B
| $1.57M | 0.01% |
30,120
-94
| -0.3% | -$5.82K |
|
659
MarketAxess Holdings
MKTX
$4.15B
| $1.56M | 0.01% |
7,035
-738
| -9% | -$189K |
|
660
NiSource
NI
$22.4B
| $1.54M | 0.01% |
61,332
+774
| +1% | +$22.8K |
|
|
ABMD
661
DELISTED
Abiomed Inc
ABMD
| $1.52M | 0.01% |
6,205
-681
| -10% | -$184K |
|
662
Snowflake
SNOW
$92.9B
| $1.52M | 0.01% |
8,955
-160
| -2% | -$26.5K |
|
663
Bio-Techne
TECH
$11.2B
| $1.51M | 0.01% |
21,320
-2,468
| -10% | -$213K |
|
664
Las Vegas Sands
LVS
$30.5B
| $1.51M | 0.01% |
40,259
-32,380
| -45% | -$1.21M |
|
665
Targa Resources
TRGP
$60.4B
| $1.5M | 0.01% |
24,842
-753
| -3% | -$49.5K |
|
666
First Horizon
FHN
$12.1B
| $1.5M | 0.01% |
65,361
-1,895
| -3% | -$43.1K |
|
667
United Therapeutics
UTHR
$26.3B
| $1.48M | 0.01% |
7,042
+283
| +4% | +$63.3K |
|
668
Leidos
LDOS
$14.1B
| $1.47M | 0.01% |
16,821
-2,084
| -11% | -$204K |
|
|
STOR
669
DELISTED
STORE Capital Corporation
STOR
| $1.47M | 0.01% |
46,785
+562
| +1% | +$16K |
|
|
APLS
670
DELISTED
Apellis Pharmaceuticals
APLS
| $1.44M | 0.01% |
21,068
+2,558
| +14% | +$151K |
|
671
First Solar
FSLR
$21.8B
| $1.44M | 0.01% |
10,875
-250
| -2% | -$26.8K |
|
672
Halozyme
HALO
$9.72B
| $1.43M | 0.01% |
36,252
+423
| +1% | +$18.7K |
|
673
Zions Bancorporation
ZION
$10.1B
| $1.43M | 0.01% |
28,143
-3,048
| -10% | -$167K |
|
|
HZNP
674
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $1.43M | 0.01% |
23,049
+1,383
| +6% | +$96.6K |
|
675
Healthcare Realty
HR
$7.42B
| $1.4M | 0.01% |
67,006
+37,659
| +128% | +$957K |
|
Similar funds
ProShare Advisors's Q3 2022 Portfolio in Review
As of Q3 2022, ProShare Advisors held 1,846 positions worth $26.1B, down 14% from $30.2B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
ProShare Advisors withdrew a net $2.77B in Q3 2022, closing 96 positions and reducing 1,301 holdings. Its most notable exit was Neenah, Inc. Common Stock, an estimated $7.52M position sold in full.
By sector, the portfolio is most concentrated in Technology at 24% of assets, down from 26% a quarter earlier, followed by Consumer Staples and Consumer Discretionary.
Against the trend, ProShare Advisors opened a new position in Xometry worth $7.31M.
- ProShare Advisors's largest Q3 2022 buy was Xometry: 128,758 shares worth $7.31M.
- ProShare Advisors added most to Target in Q3 2022, an estimated $49.4M increase.
- ProShare Advisors's biggest Q3 2022 reduction was Apple, cutting an estimated $366M.
- ProShare Advisors fully exited Neenah, Inc. Common Stock in Q3 2022, selling an estimated $7.52M.
- ProShare Advisors's ten largest holdings make up 23% of its $26.1B portfolio in Q3 2022.
- ProShare Advisors opened 56 new positions and closed 96 in Q3 2022.
- ProShare Advisors's portfolio value fell 14% quarter-over-quarter to $26.1B.
Based on ProShare Advisors's 13F filing for Q3 2022, filed 7 Nov 2022.